2016
DOI: 10.1016/s0140-6736(16)30072-1
|View full text |Cite
|
Sign up to set email alerts
|

Deferred versus conventional stent implantation in patients with ST-segment elevation myocardial infarction (DANAMI 3-DEFER): an open-label, randomised controlled trial

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

3
103
0
16

Year Published

2017
2017
2022
2022

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 165 publications
(122 citation statements)
references
References 28 publications
3
103
0
16
Order By: Relevance
“…(9)(10)(11) Our patient had simultaneous thrombosis in LAD and RCA, which did not fulfil the criteria of the DEFER trials. Currently, there are no guidelines for optimal management strategy …”
Section: A 2bmentioning
confidence: 94%
“…(9)(10)(11) Our patient had simultaneous thrombosis in LAD and RCA, which did not fulfil the criteria of the DEFER trials. Currently, there are no guidelines for optimal management strategy …”
Section: A 2bmentioning
confidence: 94%
“…Accordingly, a systematic and comprehensive analysis of TB may take sense in the era of bioresorbable vascular scaffolds, as STEMI patients appear to represent an attractive target for the use of these novel devices [7]. Also, TB assessment may help to identify patients for alternative strategies such as "delayed stenting", given the conflicting results of its routine application [8].…”
Section: Introductionmentioning
confidence: 99%
“…However, since stent implantation may cause intraprocedural thrombotic complications (IPTEs), including distal embolization of thrombus leading to microvascular obstruction (MVO) and no-reflow (2,3) some clinicians have questioned whether immediate stent implantation is mandated in all patients, or instead, whether stent implantation could be deferred for a limited period to enable the beneficial effects of restored blood flow and medical therapy. With this in mind, a number of clinical investigations of deferred stenting (DS) strategies have been assessed (4)(5)(6)(7)(8)(9)(10)(11)(12)(13)(14)(15)(16). This was the focus of the Minimalist Immediate Mechanical Intervention (MIMI) trial (14).…”
mentioning
confidence: 99%
“…These are associated with a larger infarct size and an adverse prognosis (21). The hypothesis underpinning a DS approach is the potential to reduce coronary thrombus burden after initial stabilization of infarct related lesion and preserve microvascular function, therefore reducing the likelihood of slow and no reflow and MVO (14)(15)(16).…”
mentioning
confidence: 99%
See 1 more Smart Citation